Search results
Jump to navigation
Jump to search
Page title matches
- '''Vancomycin''' is an antibiotic that is reserved, in intravenous form, for the treatmen ...rococci''. While there are not widespread legal requirements for reporting vancomycin-resistant strains, organizations such as the [[Infectious Disease Society o12 KB (1,633 words) - 12:06, 27 November 2010
- 12 bytes (1 word) - 16:44, 12 January 2008
- 222 bytes (26 words) - 15:12, 29 April 2009
- Auto-populated based on [[Special:WhatLinksHere/Vancomycin]]. Needs checking by a human.651 bytes (80 words) - 21:27, 11 January 2010
Page text matches
- Glycopeptide antibiotic, similar to vancomycin, used in the treatment of serious Gram-positive infections.143 bytes (16 words) - 02:45, 16 February 2010
- ...tion but is now also community-acquired; additional resistance (e.g., to [[vancomycin]]) continues to be a public health concern352 bytes (47 words) - 11:46, 27 August 2010
- ..., Mullane KM, Weiss K, Lentnek A, Golan Y et al.| title=Fidaxomicin versus vancomycin for Clostridium difficile infection. | journal=N Engl J Med | year= 2011 | ...inicaltrials.gov/ct2/show/results/NCT00468728 |title=PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) - Stu2 KB (243 words) - 13:18, 2 February 2023
- ...lable [[antibiotic]] of the [[oxazolidinone]] class, approved for complex vancomycin-resistant ''[[Enterococcus faecium]]'' infections, methicillin-resistant ''530 bytes (67 words) - 13:56, 26 November 2010
- An ''in vitro'' study showed it to have bactericidal effects, superior to [[vancomycin]] and [[teicoplanin]], against [[methicillin]]-resistant ''S. aureus''.<ref | title = (Abstract) Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection2 KB (225 words) - 21:01, 23 August 2010
- {{r|Vancomycin}}509 bytes (62 words) - 20:51, 11 January 2010
- {{r|Vancomycin}}340 bytes (37 words) - 12:09, 23 May 2010
- {{r|Vancomycin}}625 bytes (76 words) - 19:47, 11 January 2010
- Auto-populated based on [[Special:WhatLinksHere/Vancomycin]]. Needs checking by a human.651 bytes (80 words) - 21:27, 11 January 2010
- {{r|Vancomycin}}682 bytes (83 words) - 21:00, 11 January 2010
- ...Logan N, Bressler AM, Johnson DP, Rossignol JF |title=Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study |journ920 bytes (118 words) - 17:15, 7 February 2009
- {{r|Vancomycin}}758 bytes (93 words) - 11:56, 11 January 2010
- {{r|Vancomycin}}684 bytes (94 words) - 21:04, 23 August 2010
- {{r|Vancomycin}}798 bytes (98 words) - 07:44, 8 January 2010
- '''Vancomycin''' is an antibiotic that is reserved, in intravenous form, for the treatmen ...rococci''. While there are not widespread legal requirements for reporting vancomycin-resistant strains, organizations such as the [[Infectious Disease Society o12 KB (1,633 words) - 12:06, 27 November 2010
- Other [[glycopeptide antibiotic]]s include [[vancomycin]] and [[dalbavancin]].1 KB (140 words) - 03:09, 16 February 2010
- {{r|Vancomycin}}1 KB (146 words) - 21:45, 23 August 2010
- ...[[ampicillin]]; alternative is [[chloramphenicol]] plus [[gentamicin]]; [[vancomycin]] if cephalosporin-resistant ''S. pneumoniae'' is prevalent locally; dexame ...taxime or ceftriaxone plus vancomycin; alternatively chloramphenicol plus vancomycin; dexamethasone8 KB (1,102 words) - 17:12, 21 March 2024
- .../content.nejm.org/cgi/content/full/355/8/809}}</ref> Other drugs include [[vancomycin]] ...te journal |author=Von Drygalski A, Curtis BR, Bougie DW, ''et al'' |title=Vancomycin-induced immune thrombocytopenia |journal=N. Engl. J. Med. |volume=356 |issu4 KB (579 words) - 13:26, 23 November 2010
- | Use alternatives, such as [[ceftriaxone]] or [[vancomycin]], if community experience shows strong penicillin resistance | Alternative to vancomycin in sensitive patients7 KB (936 words) - 17:11, 13 June 2010
- {{r|Vancomycin}}3 KB (336 words) - 04:05, 8 June 2009
- .../articles/w1311c.html |title=Drugs for MRSA with Reduced Susceptibility to Vancomycin |author=Anonymous |authorlink= |coauthors= |date=2009 |format= |work= |publ7 KB (937 words) - 10:01, 5 January 2011
- {{r|Vancomycin}}4 KB (505 words) - 16:36, 11 January 2010
- ...ion with MRSA, injection drug use, or SIRS (severe nonpurulent; Figure 1), vancomycin or another antimicrobial effective against both MRSA and streptococci is re ** [[vancomycin]] at least 30 mg/kg/day8 KB (1,120 words) - 13:33, 23 August 2014
- ...=Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A |title=High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficac9 KB (1,169 words) - 02:01, 29 October 2013
- ...rict it to controlled hospital use, only for specific strains. Eventually, vancomycin resistance was seen among staphylococci; acquired resistance was first obse14 KB (1,922 words) - 12:55, 8 March 2015
- ...author=Zar FA, Bakkanagari SR, Moorthi KM, Davis MB| title=A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated dia ...| Fidaxomicin<br/>• 200 mg twice daily<br/>• 10 days ||Vancomycin<br/>• 125 mg 4 times/day<br/>• 10 days ||stool toxin af46 KB (6,252 words) - 17:10, 31 October 2013
- ...or=Vesga O, Agudelo M, Salazar BE, Rodriguez CA, Zuluaga AF| title=Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innov18 KB (2,553 words) - 13:17, 2 February 2023
- * [[Vancomycin]]9 KB (1,048 words) - 17:19, 21 March 2024
- ...c devices were used in a trauma case in 2003. Even though, the antibiotic, vancomycin, was the treatment of choice, it was not successful in the recovery of the ...is'' is highly resistant to most antibiotics and lightly resistant to only vancomycin, it is very difficult to treat the nosocomial infections. But a class of an18 KB (2,382 words) - 03:24, 16 February 2010
- ...fected by substances such as amoxicillin,erythromycin, chloramphenicol and vancomycin. However, the susceptibility for trimethoprim, ciprofloxin and tetracyclin10 KB (1,508 words) - 21:37, 14 February 2010
- ...f> In addition, in 2005 LGG was used to treat gastrointestinal carriage of vancomycin-resistant enterococci in patients with kidney problems.<ref>{{cite web|last11 KB (1,707 words) - 00:27, 15 November 2013
- ** [[vancomycin]] at least 30 mg/kg/day27 KB (3,654 words) - 12:46, 22 November 2015
- * [[Vancomycin]]25 KB (3,396 words) - 13:29, 2 April 2024